156 related articles for article (PubMed ID: 20514448)
1. Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway.
Wen YG; Wang Q; Zhou CZ; Qiu GQ; Peng ZH; Tang HM
Oncol Rep; 2010 Jul; 24(1):89-95. PubMed ID: 20514448
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
3. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
4. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
5. PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3β/β-Catenin Signaling Pathway in Human Gastric Cancer.
Ma J; Guo X; Zhang J; Wu D; Hu X; Li J; Lan Q; Liu Y; Dong W
Dig Dis Sci; 2017 Dec; 62(12):3415-3425. PubMed ID: 29030742
[TBL] [Abstract][Full Text] [Related]
6. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
[TBL] [Abstract][Full Text] [Related]
7. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
8. PI3K/AKT pathway activation in bladder carcinogenesis.
Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
[TBL] [Abstract][Full Text] [Related]
9. Molecular changes in the phosphatidylinositide 3-kinase (PI3K) pathway are common in gastric cancer.
Tran TN; Brettingham-Moore K; Duong CP; Mitchell C; Clemons NJ; Phillips WA
J Surg Oncol; 2013 Aug; 108(2):113-20. PubMed ID: 23813545
[TBL] [Abstract][Full Text] [Related]
10. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
[TBL] [Abstract][Full Text] [Related]
12. Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece.
Sozopoulos E; Litsiou H; Voutsinas G; Mitsiades N; Anagnostakis N; Tseva T; Patsouris E; Tseleni-Balafouta S
Endocr Pathol; 2010 Jun; 21(2):90-100. PubMed ID: 20186503
[TBL] [Abstract][Full Text] [Related]
13. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells.
Akca H; Demiray A; Tokgun O; Yokota J
Lung Cancer; 2011 Sep; 73(3):302-9. PubMed ID: 21333374
[TBL] [Abstract][Full Text] [Related]
14. The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.
Riquelme I; Tapia O; Espinoza JA; Leal P; Buchegger K; Sandoval A; Bizama C; Araya JC; Peek RM; Roa JC
Pathol Oncol Res; 2016 Oct; 22(4):797-805. PubMed ID: 27156070
[TBL] [Abstract][Full Text] [Related]
15. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
Bittinger S; Alexiadis M; Fuller PJ
Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
[TBL] [Abstract][Full Text] [Related]
16. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
Ogawa K; Sun C; Horii A
Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
[TBL] [Abstract][Full Text] [Related]
17. Mutation of genes of the PI3K/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness.
Tserga A; Chatziandreou I; Michalopoulos NV; Patsouris E; Saetta AA
Virchows Arch; 2016 Jul; 469(1):35-43. PubMed ID: 27059323
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR-7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway.
Pan H; Li T; Jiang Y; Pan C; Ding Y; Huang Z; Yu H; Kong D
J Cell Biochem; 2018 Jan; 119(1):440-446. PubMed ID: 28608528
[TBL] [Abstract][Full Text] [Related]
19. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
20. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
Chun SH; Jung CK; Won HS; Kang JH; Kim YS; Kim MS
Head Neck; 2015 May; 37(5):636-43. PubMed ID: 24616007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
